Advertisement
Screener

ADMA BIOLOGICS, INC. (ADMA) Patents: Active

ADMA BIOLOGICS, INC. Active Patents

10 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2022-05-23: Application 17750470; Invention COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNODEFICIENCY; Applicant ADMA Biologics, Inc.; Status Patented Case.
  • 2021-08-09: Application 17397915; Invention ANTI-PNEUMOCOCCAL HYPERIMMUNE GLOBULIN FOR THE TREATMENT AND PREVENTION OF PNEUMOCOCCAL INFECTION; Applicant ADMA Biologics, Inc.; Status Patented Case.
  • 2020-06-15: Application 16901993; Invention COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNODEFICIENCY; Applicant ADMA Biologics, Inc.; Status Patented Case.
  • 2019-04-15: Application 16384334; Invention ANTI-PNEUMOCOCCAL HYPERIMMUNE GLOBULIN FOR THE TREATMENT AND PREVENTION OF PNEUMOCOCCAL INFECTION; Applicant ADMA Biologics, Inc.; Status Patented Case.
FiledApplicationInventionApplicantStatusGrantedPatentPublished asInventor nameInventor countryExaminer
2022-05-2317750470COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNODEFICIENCYADMA Biologics, Inc.Patented Case2023-10-1011780906US20220403008A1
Adam S. Grossman
James Mond
Jerrold B. Grossman
Dov A. Goldstein
United States
United States
United States
United States
HILL, MYRON G
2021-08-0917397915ANTI-PNEUMOCOCCAL HYPERIMMUNE GLOBULIN FOR THE TREATMENT AND PREVENTION OF PNEUMOCOCCAL INFECTIONADMA Biologics, Inc.Patented Case2024-02-1311897943US20220023339A1
James Mond
Adam S. Grossman
United States
United States
HINES, JANA A
2020-06-1516901993COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNODEFICIENCYADMA Biologics, Inc.Patented Case2022-05-2411339206US20210130441A1
Adam S. Grossman
James Mond
Jerrold B. Grossman
Dov A. Goldstein
United States
United States
United States
United States
HILL, MYRON G
2019-04-1516384334ANTI-PNEUMOCOCCAL HYPERIMMUNE GLOBULIN FOR THE TREATMENT AND PREVENTION OF PNEUMOCOCCAL INFECTIONADMA Biologics, Inc.Patented Case2021-08-1011084870US20190241646A1
James Mond
Adam S. Grossman
United States
United States
HINES, JANA A
2018-05-1415978692COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNODEFICIENCYADMA Biologics, Inc.Patented Case2020-06-1610683343US20180258159A1
Adam S. Grossman
James Mond
Jerrold B. Grossman
Dov A. Goldstein
United States
United States
United States
United States
HILL, MYRON G
2017-11-1315811486COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNODEFICIENCYADMA Biologics, Inc.Patented Case2018-05-159969793US20180086818A1
Adam S. Grossman
James Mond
Jerrold B. Grossman
Dov A. Goldstein
United States
United States
United States
United States
HILL, MYRON G
2017-03-1515460147Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infectionADMA Biologics, Inc.Patented Case2019-04-1610259865US20180265574A1
James Mond
Adam S. Grossman
United States
United States
HINES, JANA A
2015-07-0214790872COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNODEFICIENCYADMA Biologics, Inc.Patented Case2017-07-259714283US20160115221A1
Adam S. Grossman
Jerrold B. Grossman
James Mond
Dov A. Goldstein
United States
United States
United States
United States
HILL, MYRON G
2015-01-0814592727COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNODEFICIENCYADMA Biologics, Inc.Patented Case2017-11-149815886US20160114037A1
Adam S. Grossman
James Mond
Jerrold B. Grossman
Dov A. Goldstein
United States
United States
United States
United States
HILL, MYRON G
2015-01-0814592721COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNODEFICIENCYADMA Biologics, Inc.Patented Case2015-08-189107906
Adam S. Grossman
James Mond
Jerrold B. Grossman
United States
United States
United States
HILL, MYRON G

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Greenland Mines Ltd (GRML)United States$2.362B
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
NOVAVAX INC (NVAX)United States$1.748B-6.26
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43